Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00301990
Title Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Jonsson Comprehensive Cancer Center
Indications

renal cell carcinoma

Therapies

Aldesleukin + Bevacizumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.